Eli Lilly Raises Full-Year Forecast After Beating Profit and Sales Expectations
The American pharmaceutical giant Eli Lilly, Danish Novo's main competitor, is beating profit expectations and raising its forecast for the year.
BusinessThe American pharmaceutical giant Eli Lilly, Danish Novo's main competitor, is beating profit expectations and raising its forecast for the year.
Business